This channel includes news on cardiovascular care delivery, including how patients are diagnosed and treated, cardiac care guidelines, policies or legislation impacting patient care, device recalls that may impact patient care, and cardiology practice management.
Cardiovascular health is much worse in some parts of the United States than others. Cardiologists in those high-risk areas can make a world of difference by embracing preventive cardiology and working to treat patients before it is too late.
The updated recommendations represent a collaboration between the American College of Cardiology, American Heart Association and several other U.S. healthcare organizations.
When working-age adults develop cardiovascular disease, it often ends up eating up a significant amount of their income. Are insurance companies doing enough to help these patients?
Vascular surgeons play a critical role in today's evolving healthcare landscape. However, researchers noted, they often do not get the respect or appreciation they deserve.
The cardiovascular mortality rate in the United States decreased dramatically from 2000 to 2011. Since then, however, it has remained relatively unchanged.
ISC 2024 in Phoenix has already featured several eye-opening late-breaking presentations. One study, for example, found that positioning a stroke patient's head differently before surgery can significantly decrease the risk of neurological complications.
It’s not easy to get patients, providers, payers, vendors and regulators to agree on any one aspect of healthcare delivery. But the CDRH recently managed to get everyone to settle on a working definition of transparency.
One of the world's leading heart hospitals is seeing significant growth. This represents the first time it has hired four new cardiothoracic surgeons in a single 12-month period.
Americans trust nurses and doctors less than they did a few years ago, but both professions still make the top five among 23 wide and varied work roles.
The latest COVID-19 vaccine began entering recipients’ bodies last September. Now comes early CDC data supporting the formulation’s general effectiveness.
Researchers explored the potential of an alternate way to perform PFA on patients with persistent AFib, presenting their findings live at AF Symposium 2024 in Boston.
The approval, based on positive results from the TRISCEND II trial, represents a significant milestone for the treatment of severe tricuspid regurgitation.